Objective Overviews of treatment goals and influencing factors may support shared decision making and optimize customized treatment to the patient with somatic symptom disorder (SSD). The aim of this study was to identify and structure comprehensive sets of treatment goals and factors influencing goal attainment in patients with SSD from the perspective of clinicians. Methods Using a concept mapping procedure, clinicians participated in interviews (N = 17) and card sorting tasks comprising 55 treatment goals and 55 factors influencing goal attainment (N = 38). Results We identified four overarching categories (A to D) of nine clusters (1 to 9) of treatment goals: A. empowerment (A1. personal values, A2. committed action, A3. self-esteem), B...
Background: the application of group analysis for the treatment of somatoform disorders requires the...
Aims: To develop a structured goal-set for use in programs for the assessment and management of prol...
Because individual patients with persistent somatic symptoms (PSS) respond differently to treatments...
Objective Overviews of treatment goals and influencing factors may support shared decision making an...
Objective From a patient-centered perspective, treatment outcome measures in somatoform disorder nee...
Abstract Background Therapeutic intervention programs for somatic symptom disorder (SSD) show only s...
Objective: The aim of this concept mapping study was to identify the structure and alleged importanc...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: This study investigated symptom change trajectory for patients with persistent somatic sy...
Objectives Limited empirical attention has been devoted to individualized treatment objectives in in...
Somatization, the presentation of physical symptoms without an identifiable cause, is among the most...
Goal setting in psychological treatments may have favorable effects on patients' motivation and trea...
Background: the application of group analysis for the treatment of somatoform disorders requires the...
Aims: To develop a structured goal-set for use in programs for the assessment and management of prol...
Because individual patients with persistent somatic symptoms (PSS) respond differently to treatments...
Objective Overviews of treatment goals and influencing factors may support shared decision making an...
Objective From a patient-centered perspective, treatment outcome measures in somatoform disorder nee...
Abstract Background Therapeutic intervention programs for somatic symptom disorder (SSD) show only s...
Objective: The aim of this concept mapping study was to identify the structure and alleged importanc...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and p...
Objective: This study investigated symptom change trajectory for patients with persistent somatic sy...
Objectives Limited empirical attention has been devoted to individualized treatment objectives in in...
Somatization, the presentation of physical symptoms without an identifiable cause, is among the most...
Goal setting in psychological treatments may have favorable effects on patients' motivation and trea...
Background: the application of group analysis for the treatment of somatoform disorders requires the...
Aims: To develop a structured goal-set for use in programs for the assessment and management of prol...
Because individual patients with persistent somatic symptoms (PSS) respond differently to treatments...